Current prospects for the generation of patient-specific pluripotent cells from adult tissues

Regenerative Medicine

Volumn 2, Issue 5, 2007, Pages 743-752

  Agarwal, Suneet ^a   Lensch, M William ^a   Daley, George Q ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 4; MYC PROTEIN;

BONE MARROW TRANSPLANTATION; CELL ASSAY; CELL DIFFERENTIATION; CELL FUSION; CELL NUCLEUS TRANSPLANTATION; DNA METHYLATION; EDITORIAL; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ENDOCRINE DISEASE; GAMETOGENESIS; GENETIC CODE; GENETIC DISORDER; GERM LINE; HEMATOLOGIC DISEASE; HETEROZYGOSITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPOTENT STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NONHUMAN; ONCOGENE; OOCYTE; PARTHENOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; SOMATIC CELL; SPERMATOZOON; STEM CELL TRANSPLANTATION; TESTIS CELL; TISSUE REGENERATION; TISSUE TRANSPLANTATION;

ADULT; ADULT STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 35048895721     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.5.743     Document Type: Editorial

References (62)

1. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH: Viable offspring derived from fetal and adult mammalian cells. Nature 385(6619), 810-813 (1997).
2. Cibelli J: Developmental biology. A decade of cloning mystique. Science 316(5827), 990-992 (2007).
3. Kawase E, Yamazaki Y, Yagi T, Yanagimachi R, Pedersen RA: Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocysts. Genesis 28(3-4), 156-163 (2000).
4. Munsie MJ, Michalska AE, O'Brien CM et al.: Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr. Biol. 10(16), 989-992 (2000).
5. Wakayama T, Tabar V, Rodriguez I et al.: Differentiation of embryonic stem cell lines generated from adult somatic cells by nuclear transfer. Science 292(5517), 740-743 (2001).
6. Keller G: Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19(10), 1129-1155 (2005).
7. Trounson A: The production and directed differentiation of human embryonic stem cells. Endocr. Rev. 27(2), 208-219 (2006).
8. Rideout WM, 3rd, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R: Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109(1), 17-27 (2002).
9. Briggs R, King, TJ: Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc. Natl Acad. Sci. USA 38(5), 455-463 (1952).
10. Gordon JB, Byrne JA: The first half-century of nuclear transplantation. Proc. Natl Acad. Sci. USA 100(14), 8048-8052 (2003).
11. Hochedlinger K, Jaenisch R: Monoclonal mice generated by nuclear transfer from mature B and T donor cells. Nature 415(6875), 1035-1038 (2002).
12. Eggan K, Baldwin K, Tackett M et al.: Mice cloned from olfactory sensory neurons. Nature 428(6978), 44-49 (2004).
13. Li J, Ishii T, Feinstein P, Mombaerts P: Odorant receptor gene choice is reset by nuclear transfer from mouse olfactory sensory neurons. Nature 428 (6981). 393-399 (2004).
14. Hochedlinger K, Blelloch R, Brennan C et al.: Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 18(15), 1875-1885 (2004).
15. Hwang WS, Roh SI, Lee BC et al.: Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 308(5729), 1777-1783 (2005).
16. Hwang WS, Ryu YJ, Park JH et al.: Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 303(5664), 1669-1674 (2004).
17. Kennedy D: Editorial retraction. Science 311(5759), 335 (2006).
18. Simerly C, Dominko T, Navara C et al.: Molecular correlates of primate nuclear transfer failures. Science 300(5617), 297 (2003).
19. Baker M: Monkey stem cells cloned. Nature 447(7147), 891 (2007).
20. National Research Council: Appendix B: Animal Reproductive Cloning Data Tables on Reproductive Cloning Efficiency and Defects. In: Scientific and Medical Aspects of Human Reproductive Cloning. National Academies Press, Washington, DC, USA, 111-143 (2002).
21. Egli D, Rosains, J, Birkhoff G, Eggan K: Developmental reprogramming after chromosome transfer into mitotic mouse zygotes. Nature 447(7145), 679-685 (2007).
22. Devereaux M: Is the search for alternative sources of human pluripotent stem cells a mistake? Stem Cell Rev 1(4), 331-336 (2005).
23. Green RM: Can we develop ethically universal embryonic stem-cell lines? Nat. Rev. Genet. 8(6), 480-485 (2007).
24. Guenin LM: Wishful thinking will not obviate embryo use. Stein Cell Rev 1(4), 309-316 (2005).
25. Hurlbut WB: Altered nuclear transfer: a way forward for embryonic stem cell research. Stem Cell Rev 1(4), 293-300 (2005).
26. Kalichman MW, Hinman LM, Snyder EY: Exploring common ground in the stem cell ethical debate-A Perspective for scientists: introduction to this special issue of stem cell reviews. Stem Cell Rev 1(4), 285-286 (2005).
27. Schulman A: The search for alternative sources of human pluripotent stem cells. Stem Cell Rev 1(4), 291-292 (2005).
28. Miller RA, Ruddle FH: Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 9(1), 45-55 (1976).
29. Cowan CA, Atienza J, Melton DA, Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (5739), 1369-1373 (2005).
30. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11(19), 1553-1558 (2001).
31. Yu J, Vodyanik MA, He P, Slukvin II. Thomson JA: Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 24(1), 168-176 (2006).
32. Do JT, Schuler HR: Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22(6), 941-949 (2004).
33. Strelchenko N, Kukharenko V. Shkumatov A et al.: Reprogramming of human somatic cells by embryonic stem cell cytoplast. Reprod. Biomed Online 12(1), 107-111 (2006).
34. Silva J, Chambers I, Pollard S. Smith A: Nanog promotes transfer of pluripotency after cell fusion. Nature 441(7096), 997-1001 (2006).
35. Matsumura H, Tada M, Otsuji T et al.: Targeted chromosome elimination from ES-somatic hybrid cells. Nat. Methods 4(1), 23-25 (2007).
36. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4), 663-676 (2006).
37. Maherali N, Sridharan R, Xie W et al.: Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70 (2007).
38. Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448 (7151), 313-317 (2007).
39. Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448(7151), 318-324 (2007).
40. Yamanaka S: Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1, 39-49 (2007).
41. Cyranoski D: Simple switch turns cells embryonic. Nature 447(7145), 618-619 (2007).
42. Donovan PJ, de Miguel MP: Turning germ cells into stem cells. Curr. Opin. Genet. Dev. 13(5), 463-471 (2003).
43. Kanatsu-Shinohara M, Inoue K, Lee J et al.: Generation of pluripotent stem cells from neonatal mouse testis. Cell 119(7), 1001-1012 (2004).
44. Guan K, Nayernia K, Maier LS et al.: Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 440(7088), 1199-1203 (2006).
45. Cyranoski D: Stem cells from testes: could it work? Nature 440(7084), 586-587 (2006).
46. Gold JD, Pedersen RA: Mechanisms of genomic imprinting in mammals. Curr. Top. Dev. Biol. 29, 227-280 (1994).
47. Narasimha M, Barton SC, Surani MA: The role of the paternal genome in the development of the mouse germ line. Curr. Biol. 7(11), 881-884 (1997).
48. Stevens LC: Totipotent cells of parthenogenetic origin in a chimaeric mouse. Nature 276(5685), 266-267 (1978).
49. Barton SC, Ferguson-Smith AC, Fundele R, Surani MA: Influence of paternally imprinted genes on development. Development 113(2), 679-687 (1991).
50. Mann JR, Gadi I, Harbison ML, Abbondanzo SJ, Stewart CL: Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: implications for genetic Imprinting. Cell 62(2), 251-260 (1990).
51. McLaughlin KJ, Kochanowski H, Solter D et al.: Roles of the imprinted gene Igf2 and paternal duplication of clistal chromosome 7 in the perinatal abnormalities of androgenetic mouse chimeras. Development 124(23), 4897-4904 (1997).
52. Hernandez L, Kozlov S, Piras G, Stewart CL: Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc. Natl Acad. Sci. USA 100(23), 13344-13349 (2003).
53. Eckardt S, Leu NA, Bradley HL et al.: Hematopoietic reconstitution with androgenetic and gynogenetic stem cells. Genes Dev. 21(4), 409-419 (2007).
54. Strain L, Warner JP, Johnston T, Bonthron DT: A human parthenogenetic chimaera. Nat. Genet. 11(2), 164-169 (1995).
55. Rougier N, Werb, Z: Minireview: Parthenogenesis in mammals. Mol. Reprod. Dev. 59(4), 468-474 (2001).
56. Allen ND, Barton SC, Hilton K, Norris ML, Surani MA: A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 120(6), 1473-1482 (1994).
57. Hoglund P, Sundback J, Olsson-Alheim MY et al.: Host MHC class I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155, 11-28 (1997).
58. Kim K, Lerou P, Yibuuchi A et al.: Histocompatible embryonic stem cells by parthenogenesis. Science 315(5811), 482-486 (2007).
59. Kubiak J, Paldi A, Weber M, Maro B: Genetically identical parthenogenetic mouse embryos produced by inhibition of the first meiotic cleavage with cytochalasin D. Development 111(3), 763-769 (1991).
60. Revazova ES, Turovets NA, Kochetkova OD et al.: Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells (2007) (Epub ahead of print).
61. Kim K, Ng K, Rugg-Gunn PJ et al.: Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell (2007) (In press)
62. Kohn, DB, Sadelain M, Glorioso JC: Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer 3(7) 477-488 (2003).